Screener
Viking Therapeutics VKTX Invested capital
Discontinued — last reported Q4 '25
Invested capital at other companies
Other financials
Where this comes from
Calculated from Viking Therapeutics’s reported figures.
The source filing: Viking Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 29, 2026, 9:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-193315
FAQ
- What is Viking Therapeutics's invested capital?
- Viking Therapeutics (VKTX) reported invested capital of $473.39M in Q4 2025.
- How has Viking Therapeutics's invested capital changed year-over-year?
- Viking Therapeutics's invested capital decreased by 44.6% year-over-year, from $854.72M to $473.39M.
- What is the long-term trend for Viking Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Viking Therapeutics's invested capital has grown at a 17.0% compound annual growth rate (CAGR), from $215.59M to $473.39M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Viking Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude